Smith Thornton Advisors LLC Merck & Co., Inc. Transaction History
Smith Thornton Advisors LLC
- $161 Billion
- Q1 2025
A detailed history of Smith Thornton Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 4,367 shares of MRK stock, worth $372,068. This represents 0.24% of its overall portfolio holdings.
Number of Shares
4,367
Previous 5,098
14.34%
Holding current value
$372,068
Previous $507 Million
22.71%
% of portfolio
0.24%
Previous 0.32%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,905Shares Held
1.85BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$21.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.3 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.21 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.76 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $216B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...